Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Why choose index funds over active funds? Because broad diversification, lower costs, and proven long-term results often beat active management.
26,956 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Insmed disclosed that Japan now hosts more MAC lung disease patients than the United States, a development that could...
Jay-Z, now valued at roughly $2.8 billion, argues that demonizing wealth misses the bigger fixes to inequality. The s...
XRP trades around $1.35 after Ripple unveils an AI security upgrade for the XRP Ledger. Yet the market remains subdue...
Investors confront a triple threat as rating concerns, tariff fights, and Middle East risk collide, putting Indonesia...
LoanDepot posted a larger first-quarter loss as market volatility and thinner gain-on-sale margins weighed on revenue...
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
A key Michigan district flipped Democrat in a special election, signaling rising concern over inflation and auto tari...
Gabe Bodner, a veteran lender now leading OneTrust Home Loans' reverse mortgage unit, outlined a branding-focused str...
Veteran trader Peter Brandt projects a Bitcoin price path to between 300,000 and 500,000, contingent on the four-year...
Markets sold off Monday as U.S.-Iran ceasefire talks stalled, sending oil higher and pulling down stock futures. Anal...
Onsemi posted weaker Q1 2026 results amid a slowing silicon carbide market and rising competition from Sony in image ...